Summary
The unequivocal diagnosis of Alzheimer disease (AD) rests on histopathological evidence at brain autopsy or biopsy. Although the histological features of AD are well known, defining criteria for the morphological diagnosis of AD is difficult due to the phenotypical heterogeneity of the disease, absence of specific markers, and overlap of AD pathology with that observed in non-demented elderly individuals. This gray zone between normal to pathological aging and full-fledged AD represents an important diagnostic problem and should be overcome by better standardized criteria that will allow to minimize interrater and interlaboratory variability in the diagnosis of AD. Current criteria for the neuropathological diagnosis of AD are based on age-related (semi)quantitative assessment of “senile” plaques (NIA criteria), neuritic plaques (CERAD), plaques and neurofibrillary tangles in neocortex and hippocampus (Tierney et al., 1988), and staging of hierarchic spreading of neuritic AD changes, in particular, neurofibrillary tangles (Braak and Braak, 1991). All these algorithms have some weaknesses and do not recognize the various subtypes of AD. Multivariant analysis of an autopsy series of elderly subjects revealed significant correlations between psychostatus assessed by the Mini-Mental State and both the CERAD criteria and Braak staging. Although the role of plaques and tangles in the pathogenesis of AD and their relationship to both neuronal loss and dementia remain to be elucidated, clinicopathological studies have shown that both lesions, if present in sufficient numbers, particularly in the neocortex, are considered the best correlates for AD related dementia. Recent consensus recommendations of the NIA-and Reagan Institute Working Group for the morphological diagnosis of AD consider AD as a heterogenous clinicopathological entity. After exclusion of other causes of dementia, the likelihood that AD accounts for dementia is considered high, intermediate or low according to the frequency of neuritic AD lesions with regard to both the CERAD criteria and Braak staging. The evaluation of small autopsy series according to these criteria demonstrated their easy and rapid application in AD and non-demented subjects, with much less reliability for other dementing disorders.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Arriagada PV, Growdon JH, Hedley-Whyte T, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 42: 631–639
Bancher C, Jellinger K, Lassmann H, Fischer P, Leblhuber F (1996) Correlations between mental state and quantitative neuropathology in the Vienna Prospective Longitudinal Study on Dementia. Eur Arch Psychiatry Clin Neurosci 246: 137–146
Bancher C, Egensperger R, Kösel S, Jellinger K, Graeber MB (1997a) Low prevalence of apolipoprotein E ɛ4 allele in the neurofibrillary tangle predominant form of senile dementia. Acta Neuropathol 94: 403–409
Bancher C, Lassmann H, Breitschopf H, Jellinger K (1997) Mechanisms of cell death in Alzheimer’s disease. J Neural Transm [Suppl] 50: 141–152
Bancher C, Paulus W, Paukner K, Jellinger K (1997c) Neuropathological diagnosis of Alzheimer’s disease: consensus between practicing neuropathologists? Alz Dis Assoc Disord 11: 207–219
Beach TG, Honer WG, Hughes LH (1997) Cholinergic fibre loss associated with diffuse plaques in the non-demented elderly: the preclinical stage of Alzheimer’s disease? Acta Neuropathol 93: 146–151
Bennett DA, Cochran EJH, Saper CB (1993) Pathological changes in frontal cortex from biopsy to autopsy in Alzheimer’s disease. Neurobiol Aging 14: 589–596
Berg L, McKeel DW, Miller JP, Barty J, Morris JC (1993) Neuropathological indexes of Alzheimer’s disease in demented and nondemented persons aged 80 years and older. Arch Neurol 50: 349–358
Bierer LM, Haroutunian V, Gabriel S, Knott PJ, Carlin LS, Purohit DP, Perl DP, Schmeidler J, Kanof P, Davis KL (1995a) Neurochemical correlates of dementia severity in Alzheimer’s disease: relative importance of the cholinergic deficits. J Neurochem 64: 749–760
Bierer LM, Hof PR, Purohit DP, Carlin L, Schmeidler J, Davis KL, Perl DP (1995b) Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer’s disease. Arch Neurol 52: 81–88
Blacker D, Albert MS, Bassett SS, Go RC, Harrell LE, Folstein MF (1994) Reliability and validity of NINCDS-ADRDA criteria for Alzheimer’s disease. The National Institute of Mental Health Genetics Initiative. Arch Neurol 51: 1198–1204
Blennow K, Bogdanovic N, Alafuzoff I, Ekman R, Davidson P (1996) Synaptic pathology in Alzheimer’s disease: relation to severity of dementia but not to senile plaques neurofibrillary tangles or the Apo E 4 allele. J Neural Transm 103: 603–618
Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239–259
Braak H, Braak E (1994) Pathology of Alzheimer’s disease. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 585–613
Braak H, Braak E (1996) Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol 92: 197–201
Braak H, Duyckaerts C, Braak E, Piette F (1993) Neuropathological staging of Alzheimer-related changes correlates with psychometrically assessed intellectual status. In: Corain B et al (eds) Alzheimer’s disease advances in clinical and basic research. Wiley, Chichester, pp 131–137
Brown J, Lantos PL, Roques P, et al (1996) Familial dementia with swollen achromatic neurons and corticobasal inclusion bodies: a clinical and pathologic study. J Neurol Sci 135: 21–30
Callahan LM, Coleman PD (1995) Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer’s disease. Neurobiol Aging 16: 311–314
Chui HC, Tierney M, Zarow C, Lewis A, Sobel E, Perlmutter LS (1993) Neuropathologic diagnosis of Alzheimer disease: interrater reliability in the assessment of senile plaques and neurofibrillary tangles. Alz Dis Assoc Disord 7: 48–54
Chui H, Zhang Q, Victoroff J, Zaias B (1996) Differentiating Alzheimer disease and vascular dementia: reframing the question. In: Becker P, Giacobini F (eds) Alzheimer’s disease: from molecular biology to therapy. Birkhäuser, Boston, pp 13–17
Corey-Bloom J, Sabbagh MN, Hansen LA, et al (1997) “Plaque-only” Alzheimer’s disease: a clinical and pathologic examination. Neurology 48: A103
Crystal HA, Dickson DW, Slowinski MJ, Lipton RB, Grober E, Marks-Nelson H, Antis P (1993) Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol 34: 566–573
Cummings PJ, Pike CJ, Shankle R, Cotman CW (1996) Beta-amyloid deposition and other measures of neuropathology predict cogntive status in Alzheimer’s disease. Neurobiol Aging 17: 921–933
DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severity. Ann Neurol 27: 457–464
Delaere P, Duyckaerts C, He Y, Piette F, Hauw JJ (1991) Subtypes and differential laminar distribution of βA4 deposits without neuritic plaques or tangles in Alzheimer’s disease: relationship with the intellectual status of 26 cases. Acta Neuropathol 81: 328–338
Dickson DW (1997) The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56: 321–339
Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, Yen SM, Aronson MN (1991) Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 13: 179–189
Dickson DW, Crystal HA, Bevona C, Honer W, Vincent I, Davies P (1995) Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging 16: 285–304
Esiri MM, Hyman BT, Beyreuther K, Masters CL (1997) Ageing and dementia. In: Graham DI, Lantos PL (eds) Greenfield’s neuropathology, 6th ed. Arnold, London, pp 152–233
Etiene D, Kraft J, Wands JR, Gomez-Isla T, Hamyn BT, Hedley-White ET, de la Monte SM (1997) Cerebral infarction contributes to the heterogeneity of Alzheimer’s disease (abstr). J Neuropathol Exp Neurol 56: 617
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 12: 189–198
Foster NL, Wolhelmsen K, Sima AAF, et al (1997) Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Ann Neurol 41: 706–715
Galasko D, Hansen LA, Katzman R, Widerholt W, Masliah E, Terry RD, Hill LR, Lessin P, Thal LJ (1994) Clinical-neuropathological correlations in Alzheimer’s disease and related dementias. Arch Neurol 51: 888–895
Gearing M, Mirra SS (1997) Alzheimer’s disease with concomitant Parkinson’s disease changes: Two subgroups defined by neurofibrillary pathology (abstr). J Neuropathol Exp Neurol 56: 616
Gearing M, Mirra SS, Hedreen JC, Sumi SM, Hansen LA, Heyman A (1995) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD), part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer’s disease. Neurology 45: 461–461
Gearing M, Schneider LA, Mori H, Mirra SS (1996) Progression of Alzheimer’s disease pathology from biopsy to autopsy (abstr). J Neuropathol Exp Neurol 62: 64
Geddes JW, Tekirian TL, Soultanian NS, et al (1997) Comparison of neuropathologic criteria for the diagnosis of Alzheimer’s disease. Neurobiol Aging 18[Suppl 1]: S99-S105
Gertz HJ, Xuereb JH, Huppert FA, et al (1996) The relationship between clinical dementia and neuropathological staging (Braak) in a very elderly community sample. Eur Arch Psychiatry Clin Neurosci 246: 152–156
Gertz HJ, Xuereb J, Huppert F, Brayne C, et al. (1998) Examination of the validity of the hierarchical model of neuropathological staging in normal aging and Alzheimer’s disease. Acta Neuropathol 95: 154–158
Giannakopoulos P, Hof PR, Kovari E, Vallet P, Hermann FR, Bouras C (1996) Distinct patterns of neuronal loss and Alzheimer’s disease lesion distribution in elderly individuals older than 90 years. J Neuropathol Exp Neurol 55: 1210–1220
Gomez-Igla T, Price T, Hyman BT, Morris DW, Growdon JH, Hyman BT (1996) Profound loss of layer II of entorhinal cortex neurons in very mild Alzheimer’s disease. J Neurosci 16: 4491–4500
Hansen LA, Masliah E, Galasko D, Terry RD (1993) Plaque-only Alzheimer disease is usually the Lewy body variant and vice versa. J Neuropathol Exp Neurol 52: 648–654
Heinonen O, Soininen H, Sorvari H, Kosunen O, Paljärvi I, Koivisto E, Riekkienen PJ (1995) Loss of synaptophysin-like immunoreactivity in the hippocampal formation as an early phenomenon in Alzheimer’s disease. Neuroscience 64: 375–384
Hof PR, Morrison JH (1994) The cellular basis of cortical disconnection in Alzheimer disease and related dementing conditions. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer disease. Raven Press, New York, pp 197–229
Hsiao K, Chapman P, Nilsen S, et al (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274: 99–102
Hyman BT (1996) Anatomy of pathological alterations in Alzheimer’s disease. In: Wlasco W, Tanzi E (eds) Molecular mechanisms of dementia. Humana Press, Totowa, NJ, pp 219–223
Hyman BT, Trojanowski JQ (1997) Editorial on Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56: 1095–1097
Ikeda K, Akiyama H, Arai T, Sahara N, Mori H, Usami M, Sakata M, Mizutani T, Wakabayashi K, Takahashi H (1997) A subset of senile dementia high incidence of the ApoE e2 allele. Ann Neurol 41: 693–695
Jellinger KA (1996) Structural basis of dementia in neurodegenerative disorders Neuropathological overview. J Neural Transm [Suppl] 47: 1–29
Jellinger KA, Bancher C (1997) Proposals for re-evaluation of current autopsy criteria for the diagnosis of Alzheimer’s disease. Neurobiol Aging 18: S4: S55–S65
Kasa P, Rakonczay Z, Gulyai K (1997) The cholinergic system in Alzheimer’s disease. Progr Neurobiol 52: 511–535
Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, Renbig X, Peck A (1988) Clinical pathological and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 23: 138–144
Khachaturian ZS (1985) Diagnosis of Alzheimer’s disease. Arch Neurol 42: 1097–1105
Klatka LA, Schiffer RB, Powers JM, Kazee AM (1996) Incorrect diagnosis of Alzheimer’s disease A clinicopathological study. Arch Neurol 53: 35–42
Kosunen O, Soininen H, Paljarvi L, Heinonen O, Talasniemi S, Riekkinen S (1996) Diagnostic accuracy of Alzheimer’s disease: a neuropathologic study. Acta Neuropathol 91: 185–193
Lassmann H, Weiler R, Fischer P, Bancher C, Jellinger K (1992) Synaptic pathology in Alzheimer’s disease: immunological data for markers of synaptic and large dense core vesicles. Neuroscience 46: 1–8
Lassmann H, Bancher C, Breitschopf H, Wegiel F, Bobinski M, Jellinger K, Wisniewski HM (1995) Cell death in Alzheimer’s disease evaluated by DNA fragmentation in situ. Acta Neuropathol 89: 35–41
Litvan I, Hauw JJ, Bartko JJ, et al (1996) Validity and reliability of the preliminary NINDS neuropathological criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55: 97–105
Mackenzie IRA (1994) Senile plaques do not progressively accumulate with normal aging. Acta Neuropathol 87: 520–525
Mackenzie IRA, McLachlan RS, Kubu CS, Miller LA (1996) Prospective neuro-psychological assessment of nondemented patients with biopsy proven senile plaques. Neurology 46: 425–429
Masliah E, Mallory M, Alford M, Ge N, Mucke L (1995) Abnormal synaptic regeneration in hAPP695 transgenic and APOE knockout mice. In: Iqbal K, Mortimer JA, Winblad B, Wisniewski HM (eds) Research advances in Alzheimer’s disease and related disorders. Wiley, London, pp 405–414
McKee AC, Kosik KS, Kowall NW (1992) Neuritic pathology and dementia in Alzheimer’s disease. Ann Neurol 30: 156–165
McKeel DW Jr, Ball MJ, Price JL, Smith DS, Miller JP, Berg L (1993) Interlaboratory histopathologic assessment of Alzheimer’s neuropathology: different methodologies yield comparable diagnostic results. Alz Dis Assoc Disord 7: 136–153
McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Loverstone S, Collerton D, Jansen ENH, de Vos RAI, Wilcock GK, Jellinger KA, Perry RH (1996) Clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the CDLB International Workshop. Neurology 47: 1113–1124
Mirra SS, Heyman A McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Van Belle G, Berg L (1991) The Consortium to establish a registry for Alzheimer’s disease (CERAD) II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41: 479–486
Mirra SS, Hart MN, Terry RD (1993) Making the diagnosis of Alzheimer’s disease. Arch Pathol Lab Med 117: 132–144
Mirra SS, Gearing M, McKeel D, Crain BJ, Hughes JP, Van Belle G, Heyman A (1994) Interlaboratory comparison of neuropathology assessments in Alzheimer’s disease: a study of the Consortium to Establish a Registry for Alzheimer’s disease (CERAD). J Neuropathol Exp Neurol 53: 303–315
Mirra SS, Gearing M, Nash F (1997) Neuropathologica assessment of Alzheimer’s disease. Neurology 49[Suppl 3]: S14–S16
Morris JC, Storandt M, McKeel DW, Rubin EH, Price JL, Grant EA, Berg L (1996) Cerebral amyloid deposition and diffuse plaques in “normal” aging: Evidence for presymptomatic and very mild Alzheimer’s disease. Neurology 46: 707–719
Nagy Z, Esiri MM, Jobst KA, et al (1995) Relative roles of plaques and tangles in the dementia of Alzheimer’s disease: correlations using three sets of neuropathological criteria. Dementia 6: 21–31
Nagy Z, Jobst KA, Esiri MM, et al (1996) Hippocampal pathology reflects memory deficit and brain imaging measurements in Alzheimer’s disease: Clinicopathologic correlations using three sets of pathologic diagnostic criteria. Dementia 7: 76–81
Nagy Z, Esiri MM, Cate AM, Smith AD (1997a) Cell cycle markers in the hippocampus in Alzheimer’s disease. Acta Neuropathol 94: 6–15
Nagy Z, Esiri MM, Jobst KA, et al (1997b) The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol 56: 165–170
Nagy Z, Vatter-Büttner B, Braak H, et al (1997c) Staging of Alzheimer-type pathology: an interrater-intrarater study. Dementia 8: 248–251
Newell K, Hyman B, Growdon J, Hedley-Whyte ET (1997) Evaluation of NIA-Reagan institute criteria for the neuropathological diagnosis of Alzheimer’s disease (abstr). J Neuropathol Exp Neurol 56: 593
Paulus W, Bancher C, Jellinger K (1992) Interrater reliability in the neuropathologic diagnosis of Alzheimer’s disease. Neurology 42: 329–332
Perl DP, Purohit DP, Haroutunian V (1997) Clinicopathologic correlations of the Alzheimer’s disease staging system introduced by Braak and Braak (abstr). J Neuropathol Exp Neurol 56: 577
Perry EK, Court JA, Lloyd S, Johnson M, Griffiths MH, Spurden D, Piggott MA, Turner J, Perry RH (1996) β-amyloidosis in normal aging and transmitter signaling in human temporal lobe. Ann NY Acad Sci 777: 388–392
Poirier J, Aubert I, Quirion R, et al (1996) Apolipoprotein E4 and cholinergic activity in Alzheimer’s brains. In: Becker R, Giacobini E (eds) Alzheimer disease: from molecular biology to therapy. Birkhäuser, Boston, pp 55–60
Pratt S, Prinz M, Mitrovic T, Cervos-Navarro J (1995) Neuropathological diagnostic criteria for vascular dementia. In: Cruz-Sanchez FF, Ravid R, Cuzner M (eds) Neuropathological diagnostic criteria for brain banking. IOS Press, Amsterdam, pp 55–64
Price JL, Davis PB, Morris JC, White DL (1992) The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer’s disease. Neurobiol Aging 12: 295–312
Rasmussen DX, Brandt J, Stelle C, et al (1996) Accuracy of clinical diagnosis of Alzheimer disease and clinical features of patients with non-Alzheimer disease neuropathology. Alzheimer Dis Assoc Disord 10: 180–188
Reed LA, Grabowski TJ, Schmidt ML, et al (1997) Autosomal dominant dementia with widespread neurofibrillary tangles. Ann Neurol 42: 564–572
Samuel W, Masliah E, Hill R, Butters N, Terry R (1994) Hippocampal connectivity and Alzheimer’s dementia: effects of synapse loss and tangle frequency in a two-component model. Neurology 44: 2081–2088
Samuel W, Terry RD, DeTeresa R, Butters N, Masliah E (1994) Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia. Arch Neurol 51: 772–778
Scheff SW, Price DA (1993) Synapse loss in the temporal lobe in Alzheimer’s disease. Ann Neurol 33: 190–199
Sima AAF, Defendini R, Keohane C, et al (1996) The neuropathology of chromosome 17-linked dementia. Ann Neurol 39: 734–743
Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery MR (1997) Brain infarction and the clinical expression of Alzheimer’s disease. The Nun study. JAMA 277: 813–817
Spillantini MG, Crowther RA, Goedert M (1996) Comparison of the neurofibrillary pathology in Alzheimer’s disease and familial presenile dementia with tangles. Acta Neuropathol 92: 42–48
Sumi SM, Bird TD, Nochlin D, Raskind MA (1992) Familial presenile dementia with psychosis associated with cortical neurofibrillary tangles and degeneration of the amygdala. Neurology 42: 120–127
Terry RD (1996) Basis of structural Alzheimer disease and some pathogenic concepts. In: Becker P, Giacobini F (eds) Alzheimer’s disease: from molecular biology to therapy. Birkhäuser, Boston, pp 19–23
Terry RD, Masliah E, Salmon DP (1991) Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30: 572–580
Tierney MC, Fischer H, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P (1988) The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer’s disease: clinicopathological study of 57 cases. Neurology 38: 356–364
Trojanowski JQ, Shin RW, Schmidt ML, Lee VMY (1995) Relationship between plaques tangles and dystrophic processes in Alzheimers disease. Neurobiol Aging 16: 335–340
Troncoso JC, Suknov RR, Kawas CH, Koliatsos VE (1996a) In situ labelling of dying cortical neurons in normal aging and in Alzheimer’s disease: correlations with senile plaques and disease progression. J Neuropathol Exp Neurol 55: 1134–1142
Troncoso JC, Margin LJ, Dal Forno G, Kawas CH (1996b) Neuropathology in controls and demented subjects from the Baltimore longitudinal study of aging. Neurobiol Aging 17: 365–371
Ulrich J, Spillantini MG, Goedert M, Dukas L, Stähelin HB (1992) Abundant neurofibrillary tangles without senile plaques in a subset of patients with senile dementia. Neurodegeneration 1: 257–284
Vermersch P, David JP, Frigard B, Falletbianco C, Wattez A, Petit H, Delacourte A (1995) Cortical mapping of Alzheimer pathology in brains of aged non-demented subjects. Progr Neuropsychopharmacol Biol Psychiatry 19: 1035–1047
Vickers JC (1997) A cellular mechanism for the neuronal changes underlaying Alzheimer’s disease. Neuroscience 78: 629–639
Wang D, Munoz DG (1995) Qualitative and quantitative differences in senile plaque dystrophic neurites of Alzheimer’s disease and normal aged brain. J Neuropathol Exp Neurol 54: 548–556
Wilcock GK, Esiri MM (1982) Plaques tangles and dementia. A quantitative study. J Neurol Sci 56: 343–356
Zhan S-S, Veerhuis R, Kamphorst W, Eikelenboom P (1995) Distribution of beta amyloid associated proteins in plaques in Alzheimer’s disease and in the non-demented elderly. Neurodegeneration 4: 291–297
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Wien
About this paper
Cite this paper
Jellinger, K.A. (1998). The neuropathological diagnosis of Alzheimer disease. In: Jellinger, K., Fazekas, F., Windisch, M. (eds) Ageing and Dementia. Journal of Neural Transmission. Supplementa, vol 53. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6467-9_9
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6467-9_9
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83114-4
Online ISBN: 978-3-7091-6467-9
eBook Packages: Springer Book Archive